ETFS Holding Mylan Inc

 
ETF Quotes for ETFS Holding Mylan Inc top ^
  • Holdings: Delphi Automotive PLC , Mylan Inc , United Continental Holdings Inc , Alcoa Inc , Seagate Technology PLC ,
  • Morningstar Rating: 5 Stars
Sign-up for voe investment picks

 
Stock Quotes for Mylan Inc top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 3 Stars
Sign-up for myl investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 3 Stars
Sign-up for myl investment picks

 
News Articles for Mylan Inc top ^
Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH , Sept.
Sign-up for Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus® investment picks
2014/10/3
By Ben Eisen and Sue Chang, MarketWatch NEW YORK (MarketWatch) -- Here are the stocks expected to see active trading in Friday's session: Gainers RadioShack Corp.(RSH) : Reports that the retailer had reached a financing agreement gave investors more confidence that the company could successfully restructure.
Sign-up for UPDATE: RadioShack gets a jolt from financing report; Mylan rises investment picks
Mylan Inc. (MYL) on Friday raised its third-quarter and full-year per-share earnings outlook, citing a a stronger-than-expected third quarter that included new drug approvals and launches in the U.S. The drug company said it now expects third-quarter per-share earnings to come in a range of $1.12 to $1.16, up from an earlier range of 90 cents to 95 cents, and well above the current FactSet estimate of 94 cents.
Sign-up for Mylan raises outlook after better-than-expected third quarter investment picks
-Third Quarter 2014 Financial Results Conference Call to be Held on Oct.
Sign-up for Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range investment picks
A lengthy analysis of generic drug maker Mylan Inc. (MYL) helped drive its shares up by more than 6% at one point Thursday, as ISI Group's Umer Raffat said the company's Epipen franchise has long-term prospects.
Sign-up for Analyst sees growth potential for Mylan; shares jump investment picks
- Product strengthens growing antiretroviral franchise in the U.S. - PITTSBURGH , Oct.
Sign-up for Mylan Launches Generic Combivir® investment picks
PITTSBURGH , Nov.
Sign-up for Mylan Launches Generic Loestrin 24 Fe® investment picks
2014 Adjusted Diluted EPS Guidance Range Increases to $3.54 to $3.60 PITTSBURGH , Oct.
Sign-up for Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16 investment picks
PITTSBURGH , Oct.
Sign-up for Mylan Launches Generic Viramune XR® investment picks
EpiPen® Auto-Injector Locations Designated on Updated Guide Maps and Signage New Multi-year Alliance to Increase Anaphylaxis Awareness through Multiple Educational Initiatives PITTSBURGH , Nov.
Sign-up for Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors investment picks
-Expects to be eligible for 180 days of marketing exclusivity- PITTSBURGH , Nov.
Sign-up for Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC® investment picks
Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS Canada NewsWire OTTAWA , Dec.
Sign-up for Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS investment picks
By Angela Chen Gilead Sciences Inc. will allow a subsidiary of the pharmaceutical company Mylan Inc. to have nonexclusive rights to manufacture and distribute its HIV treatment drug in 112 countries.
Sign-up for Mylan to manufacture, distribute Gilead Sciences HIV drug investment picks
PITTSBURGH and HYDERABAD, India , Dec.
Sign-up for Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries investment picks
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative Canada NewsWire LONDON and PITTSBURGH , Dec.
Sign-up for Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Mylan Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Myers Industries, Inc.  |  Next: ETFS Holding Myriad Genetics, Inc.